Monoclonal Antibodies for Imaging and Therapy
Author Information
Author(s): A.A. Epenetos, C. Kosmas
Primary Institution: Imperial Cancer Research Fund Oncology Group, Royal Postgraduate Medical School, Hammersmith Hospital
Hypothesis
Can monoclonal antibodies effectively target and treat tumors in humans?
Conclusion
Monoclonal antibodies have significant limitations in targeting tumors effectively in humans compared to animal models.
Supporting Evidence
- Monoclonal antibodies have shown poor localization to tumors in human patients compared to animal models.
- High interstitial fluid pressure in tumors may hinder the effective delivery of antibodies.
- New strategies are being explored to improve the targeting and effectiveness of monoclonal antibodies.
Takeaway
Monoclonal antibodies are like special keys that are supposed to unlock cancer cells, but they often don't work as well in people as they do in mice.
Methodology
The article reviews the development and challenges of monoclonal antibodies in cancer diagnosis and therapy.
Limitations
Monoclonal antibodies often fail to localize effectively to tumor sites in humans, achieving only a tiny fraction of the expected targeting seen in animal studies.
Want to read the original?
Access the complete publication on the publisher's website